Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...

As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...

Robert F. Kennedy Jr. and his subordinates want Americans to have more conversations with their physicians. But they also can ...

MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

Corin Cesaric is a Flex Editor at CNET. She received her bachelor's degree in journalism from the University of Missouri-Columbia. Before joining CNET, she covered crime at People Magazine and ...

In the International Journal of Extreme Manufacturing, researchers at Jilin University now report a way to measure the ...

Lisa Lawler wasn't surprised when diagnosed with breast cancer in 2025. Her mother had breast cancer and died in 2016. It seemed like cancer had become a common diagnosis for ...

An update from Profound Medical ( (TSE:PRN) ) is now available.

Scientists at the Queensland University of Technology (QUT) in Australia have developed a new saliva test that could help ...

Axogen, Inc. (AXGN) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 3:25 PM ESTCompany ParticipantsMichael Dale - President, ...